Aeon Biopharma Inc.Preferred / convertible
13F holders, Q1 2024 (March 31)30holders
1famous investor
$1.57avg. 13F price*
At the end of Q1 2024, 30 institutions reported holding Aeon Biopharma Inc. in their 13F filings. The largest holders were Davidson Kempner Capital Management LP ($532K), LMR Partners LLP ($362K) and Athos Capital Ltd ($295K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X118
- Latest filing quarter
- Q1 2024
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 10 | $200K |
Ownership 30 holders
| Davidson Kempner Capital Management LP | — | No change | 366,671 | $532K |
| LMR Partners LLP | — | No change | 249,999 | $362K |
| Athos Capital Ltd | — | No change | 25,417 | $295K |
| Wolverine Asset Management LLC | — | Add +116.9% | 189,151 | $274K |
| Aristeia Capital, L.L.C. | — | Reduce -54.2% | 164,255 | $250K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 166,666 | $242K |
| D. E. Shaw & Co. | — | No change | 154,432 | $224K |
| Q Global Advisors, LLC | — | Reduce -0.8% | 132,227 | $192K |
| Hudson Bay Capital Management LP | — | No change | 100,000 | $145K |
| Whitebox Advisors LLC | — | No change | 92,000 | $133K |
| Calamos Advisors LLC | — | No change | 83,333 | $121K |
| Goldman Sachs Group Inc. | — | No change | 79,526 | $115K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | — | No change | 74,997 | $114K |
| Kim, LLC | — | Reduce -24.0% | 63,358 | $92K |
| Sculptor Capital LP | — | No change | 50,040 | $76K |
| Dupont Capital Management Corp. | — | No change | 49,999 | $72K |
| Farallon Capital Management, L.L.C. | — | No change | 49,995 | $72K |
| Jane Street Group, LLC | — | Add +0.9% | 40,825 | $59K |
| Walleye Capital LLC | — | Reduce -39.1% | 39,549 | $57K |
| Moore Capital Management, LP | — | No change | 33,333 | $48K |
| Polar Asset Management Partners Inc. | — | No change | 27,348 | $42K |
| HRT Financial LP | — | No change | 19,029 | $27K |
| Periscope Capital Inc. | — | Reduce -89.7% | 15,500 | $22K |
| Parallax Volatility Advisers, L.P. | — | Reduce -51.4% | 12,141 | $18K |
| Walleye Trading LLC | — | Reduce -55.8% | 11,587 | $17K |
| Clear Street LLC | — | Reduce -87.9% | 6,218 | $9K |
| UBS Group AG | — | Add +450.6% | 4,900 | $7K |
| Longfellow Investment Management Co. LLC | — | No change | 1,559 | $2K |
| Robinson Capital Management, LLC | — | Reduce -23.6% | 700 | $735 |
| Bank of America Corp. | — | No change | 3 | $4 |
"% of holder's portfolio" is AEON BIOPHARMA INC's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.